CK Life Sciences
CK Life Sciences International (Holdings) Inc. (Chinese: 長江生命科技集團有限公司) (SEHK: 775), or CK Life Sciences, is the subsidiary of Cheung Kong Holdings in Hong Kong. It is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products.[1] The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002 (Former stock code: HKEX: 8222).[2][3] It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.[4][5]
References
External links